trial · primary record
Dupilumab Injection
Major Depressive Disorder
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 34 |
| Primary completion | 2028-12 |
| Primary endpoint | Interleukin-4 receptor alpha (IL-4α) |
| Registry ID | NCT07908563 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:28.914Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908563
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.